Global Financial Private Client’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $868K | Buy |
7,826
+305
| +4% | +$33.8K | 0.33% | 85 |
|
2025
Q1 | $843K | Buy |
7,521
+1,453
| +24% | +$163K | 0.32% | 88 |
|
2024
Q4 | $561K | Buy |
6,068
+5,609
| +1,222% | +$518K | 0.21% | 121 |
|
2024
Q3 | $38.5K | Buy |
459
+292
| +175% | +$24.5K | 0.02% | 341 |
|
2024
Q2 | $11.5K | Sell |
167
-150
| -47% | -$10.3K | ﹤0.01% | 434 |
|
2024
Q1 | $23.1K | Hold |
317
| – | – | 0.01% | 384 |
|
2023
Q4 | $25.7K | Hold |
317
| – | – | 0.01% | 364 |
|
2023
Q3 | $23.5K | Sell |
317
-4,605
| -94% | -$341K | 0.01% | 359 |
|
2023
Q2 | $378K | Buy |
4,922
+291
| +6% | +$22.3K | 0.19% | 126 |
|
2023
Q1 | $385K | Sell |
4,631
-96
| -2% | -$7.99K | 0.2% | 111 |
|
2022
Q4 | $406K | Buy |
4,727
+135
| +3% | +$11.6K | 0.23% | 95 |
|
2022
Q3 | $286K | Buy |
4,592
+4,275
| +1,349% | +$266K | 0.16% | 114 |
|
2022
Q2 | $19.8K | Buy |
317
+80
| +34% | +$4.99K | 0.01% | 348 |
|
2022
Q1 | $14.1K | Hold |
237
| – | – | 0.01% | 371 |
|
2021
Q4 | $17.2K | Hold |
237
| – | – | 0.01% | 348 |
|
2021
Q3 | $16.2K | Hold |
237
| – | – | 0.01% | 314 |
|
2021
Q2 | $16.4K | Hold |
237
| – | – | 0.01% | 315 |
|
2021
Q1 | $15.7K | Hold |
237
| – | – | 0.01% | 285 |
|
2020
Q4 | $13.8K | Sell |
237
-150
| -39% | -$8.74K | 0.01% | 291 |
|
2020
Q3 | $24.5K | Buy |
387
+134
| +53% | +$8.49K | 0.02% | 244 |
|
2020
Q2 | $19.2K | Sell |
253
-325
| -56% | -$24.7K | 0.02% | 299 |
|
2020
Q1 | $41.9K | Buy |
578
+48
| +9% | +$3.48K | 0.04% | 226 |
|
2019
Q4 | $34.4K | Buy |
+530
| New | +$34.4K | 0.03% | 283 |
|